Stage vs. Grade Group
Two Different Questions
When your care team discusses your prostate cancer, they use two separate systems to describe it: stage and grade group. These answer two completely different questions, and understanding the difference is essential to making sense of your diagnosis.
Grade Group answers: How aggressive do the cancer cells look?
Stage answers: How far has the cancer spread?
Grade Group — The 'How Aggressive?' Question
Grade Group (derived from the Gleason score) is determined by a pathologist examining your biopsy tissue under a microscope. It describes the cellular appearance of the cancer — how abnormal the cells look compared to normal prostate tissue.
Grade Group runs from 1 (least aggressive) to 5 (most aggressive). It does not tell you where the cancer is — only what it looks like at the cellular level.
See the Understanding Grade Groups guide for a full explanation.
Stage — The 'How Far Has It Spread?' Question
Stage describes the physical extent of the cancer — where it is located and whether it has spread beyond the prostate. Staging is determined through a combination of:
- Physical exam (digital rectal exam)
- PSA level
- Biopsy results
- Imaging studies (bone scan, CT scan, MRI, PSMA PET scan) when indicated
The TNM Staging System
Prostate cancer is staged using the TNM system:
T (Tumor)
Describes the size and local extent of the primary tumor. T1 and T2 cancers are confined to the prostate. T3 cancers have grown through the prostate capsule. T4 cancers have invaded nearby structures.
N (Nodes)
Describes whether cancer has spread to nearby lymph nodes. N0 means no lymph node involvement. N1 means cancer has spread to regional lymph nodes.
M (Metastasis)
Describes whether cancer has spread to distant sites such as bones, lungs, or liver. M0 means no distant spread. M1 means distant metastasis is present.
Before surgery, your stage is called the 'clinical stage' — it is an estimate based on available information. After surgery, when the removed prostate is fully examined, you receive a 'pathological stage,' which is more precise. The pathological stage may be higher than the clinical stage if cancer was found outside the prostate.
How Stage and Grade Work Together
Stage and grade are both used to assign you to a risk group — typically low, intermediate, or high risk. Risk groups guide treatment recommendations.
For example:
- A man with a small, localized tumor (low stage), a PSA under 10, and Grade Group 1 would likely be classified as low risk.
- A man with a higher PSA, Grade Group 3, and evidence the cancer has grown outside the prostate capsule would be classified as high risk.
Your care team uses national guidelines (such as those from the National Comprehensive Cancer Network, or NCCN) to combine your PSA, stage, and grade into a risk category that guides treatment planning.
Ask your urologist or oncologist: 'What risk category am I in — low, intermediate, or high?' This single answer summarizes how stage, grade, and PSA combine to describe your overall situation.
It is easy to hear words like "high-grade" or "aggressive" and assume that means the cancer has already spread. It does not.
Grade Group and stage tell you different things. A high Grade Group means the cancer cells look more aggressive under the microscope. Stage describes where the cancer is located and whether it has spread beyond the prostate.
A man can have high-grade prostate cancer that is still localized, just as a lower-grade cancer can sometimes require careful evaluation based on other findings.
When talking with your healthcare team, ask two separate questions:
"How aggressive is my cancer?"
"Has my cancer spread?"
Understanding the answers to both questions can make your diagnosis—and the reasons behind your treatment recommendations—much clearer.